1. Home
  2. YDESW vs KLTOW Comparison

YDESW vs KLTOW Comparison

Compare YDESW & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YDESW
  • KLTOW
  • Stock Information
  • Founded
  • YDESW N/A
  • KLTOW N/A
  • Country
  • YDESW United States
  • KLTOW United States
  • Employees
  • YDESW N/A
  • KLTOW 3
  • Industry
  • YDESW
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • YDESW
  • KLTOW Health Care
  • Exchange
  • YDESW Nasdaq
  • KLTOW Nasdaq
  • Market Cap
  • YDESW N/A
  • KLTOW N/A
  • IPO Year
  • YDESW N/A
  • KLTOW 2022
  • Fundamental
  • Price
  • YDESW $0.98
  • KLTOW $0.13
  • Analyst Decision
  • YDESW
  • KLTOW
  • Analyst Count
  • YDESW 0
  • KLTOW 0
  • Target Price
  • YDESW N/A
  • KLTOW N/A
  • AVG Volume (30 Days)
  • YDESW N/A
  • KLTOW N/A
  • Earning Date
  • YDESW N/A
  • KLTOW N/A
  • Dividend Yield
  • YDESW N/A
  • KLTOW N/A
  • EPS Growth
  • YDESW N/A
  • KLTOW N/A
  • EPS
  • YDESW N/A
  • KLTOW N/A
  • Revenue
  • YDESW N/A
  • KLTOW N/A
  • Revenue This Year
  • YDESW N/A
  • KLTOW N/A
  • Revenue Next Year
  • YDESW N/A
  • KLTOW N/A
  • P/E Ratio
  • YDESW N/A
  • KLTOW N/A
  • Revenue Growth
  • YDESW N/A
  • KLTOW N/A
  • 52 Week Low
  • YDESW N/A
  • KLTOW N/A
  • 52 Week High
  • YDESW N/A
  • KLTOW N/A
  • Technical
  • Relative Strength Index (RSI)
  • YDESW N/A
  • KLTOW 41.58
  • Support Level
  • YDESW N/A
  • KLTOW $0.13
  • Resistance Level
  • YDESW N/A
  • KLTOW $0.18
  • Average True Range (ATR)
  • YDESW 0.00
  • KLTOW 0.02
  • MACD
  • YDESW 0.00
  • KLTOW -0.00
  • Stochastic Oscillator
  • YDESW 0.00
  • KLTOW 1.79

About YDESW YD Bio Limited Warrants

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: